R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group

Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma

(2018) Eva González-Barca et al.   Oncotarget

Delivery of epirubicin via slow infusion as a strategy to mitigate chemotherapy-induced cardiotoxicity

(2017) Fang Yang et al.   PLoS One

Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma

(2016) Michael A. Fridrik et al.   EUROPEAN JOURNAL OF CANCER

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

(2015) Roberto M. Lang et al.   European Heart Journal-Cardiovascular Imaging

R-CHOP versus R-COMP: Are They Really Equally Effective?

(2014) M. Mian et al.   CLINICAL ONCOLOGY

Role of biomarkers in cardioncology

(2011) Daniela Cardinale et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

(2011) Frédéric Peyrade et al.   LANCET ONCOLOGY

Biomarker Approach to the Detection and Cardioprotective Strategies During Anthracycline Chemotherapy

(2011) Bonnie Ky et al.   Heart Failure Clinics

Role of Biomarkers in Chemotherapy-Induced Cardiotoxicity

(2010) Daniela Cardinale et al.   PROGRESS IN CARDIOVASCULAR DISEASES

Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial

(2009) S. Luminari et al.   ANNALS OF ONCOLOGY

Doxorrubicina liposomal no pegilada en combinación con ciclofosfamida, vincristina, prednisona y rituximab en el tratamiento de linfomas no hodgkinianos: estudio de 26 pacientes

(2009) Miriam Moreno et al.   MEDICINA CLINICA

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

(2008) Michael Pfreundschuh et al.   LANCET ONCOLOGY

R-COMP 21 for frail elderly patients with aggressive B-cell non-Hodgkin lymphoma: A pilot study

(2008) Giuseppe Visani et al.   LEUKEMIA & LYMPHOMA